Clinical Trial Manufacturing and Distribution Services

  • Nottingham Trent University (NTU)

F14: Notice for changes or additional information

Notice identifier: 2024/S 000-016433

Procurement identifier (OCID): ocds-h6vhtk-0458a3

Published 24 May 2024, 11:49am



Section one: Contracting authority/entity

one.1) Name and addresses

Nottingham Trent University (NTU)

50 Shakespeare Street

Nottingham

NG1 4FQ

Contact

Mark Lucas

Email

mark.lucas@ntu.ac.uk

Telephone

+44 1158488747

Country

United Kingdom

Region code

UKF14 - Nottingham

National registration number

GB 277399933

Internet address(es)

Main address

https://www.ntu.ac.uk/

Buyer's address

https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/128806


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Clinical Trial Manufacturing and Distribution Services

Reference number

NTU/24/2615/ML

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Nottingham Trent University is conducting preliminary market research to understand the capabilities and services available in the pharmaceutical sector that can support an upcoming clinical trial. This pre-market engagement aims to gather information from qualified suppliers in two distinct areas: manufacturing and distribution of fluoxetine (20mg) and a matching placebo. Responses to this request will inform our procurement strategy and may lead to a formal invitation to tender.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2024/S 000-014973


Section seven. Changes

seven.1) Information to be changed or added

seven.2) Other additional information

Extension of deadline from 10AM, 29/05/2024 to 10AM 07/06/2024 facilitate submission of pre-market engagement responses.